Orthofix Medical Inc. (NASDAQ:OFIX) Stock Has Consensus Price Target of $14.75 According to Brokerages

by · The Markets Daily

Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) has been assigned a consensus rating of “Hold” from the five analysts that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $14.75.

OFIX has been the topic of several recent analyst reports. Weiss Ratings lowered shares of Orthofix Medical from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. Canaccord Genuity Group decreased their price target on Orthofix Medical from $18.00 to $13.00 and set a “buy” rating for the company in a report on Monday, August 10th.

Get Our Latest Research Report on OFIX

Orthofix Medical Stock Down 11.8%

Shares of NASDAQ OFIX opened at $7.87 on Thursday. The company’s 50 day moving average price is $9.29 and its 200-day moving average price is $10.99. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.67 and a current ratio of 2.84. Orthofix Medical has a 52-week low of $7.81 and a 52-week high of $16.42. The company has a market capitalization of $320.55 million, a P/E ratio of -5.11 and a beta of 0.66.

Orthofix Medical (NASDAQ:OFIX – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The medical device company reported ($0.39) earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.02. Orthofix Medical had a negative net margin of 7.41% and a negative return on equity of 14.05%. The company had revenue of $210.93 million during the quarter, compared to analysts’ expectations of $209.28 million. Equities analysts forecast that Orthofix Medical will post -1.29 earnings per share for the current year.

Institutional Investors Weigh In On Orthofix Medical

Institutional investors and hedge funds have recently made changes to their positions in the business. R Squared Ltd grew its holdings in Orthofix Medical by 7.2% during the first quarter. R Squared Ltd now owns 13,518 shares of the medical device company’s stock worth $155,000 after buying an additional 904 shares in the last quarter. State of Wyoming raised its position in Orthofix Medical by 12.2% in the 1st quarter. State of Wyoming now owns 14,873 shares of the medical device company’s stock valued at $171,000 after buying an additional 1,617 shares during the last quarter. Parallel Advisors LLC lifted its stake in Orthofix Medical by 2,434.1% during the 3rd quarter. Parallel Advisors LLC now owns 3,269 shares of the medical device company’s stock valued at $31,000 after acquiring an additional 3,140 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in Orthofix Medical during the 2nd quarter valued at $30,000. Finally, Legal & General Group Plc bought a new position in Orthofix Medical during the 2nd quarter valued at $37,000. Institutional investors own 89.76% of the company’s stock.

About Orthofix Medical

(Get Free Report)

Orthofix Medical Inc is a medical device company focused on spinal and orthopedic solutions. The company develops, manufactures and distributes products designed to help treat spinal disorders, support bone healing and address orthopedic trauma and related musculoskeletal conditions.

Its product portfolio includes spinal fixation and interbody systems, biologics and bone-grafting products, bone growth stimulation devices, and technologies for spinal motion preservation and deformity correction.

See Also